Tuukka Tarvasmäki

5PUBLICATIONS
8CO-AUTHORS
Emergency medicinePredictive and prognostic markersRespiratory diseasesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock.

Mari Hongisto, Johan Lassus, Tuukka Tarvasmäki

|Oct 29, 2020
Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock.

Mikko Hänninen, Toni Jäntti, Heli Tolppanen

|May 17, 2019
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.

Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola

|Feb 09, 2019
Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study.

Alessandro Sionis, Mercedes Rivas-Lasarte, Alexandre Mebazaa

|Jul 05, 2016
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.

Tuukka Tarvasmäki, Johan Lassus, Marjut Varpula

Pageof 1

Frequent Collaborators

1 joint publications

Mercedes Rivas-Lasarte

1 joint publications

Toni Jäntti

1 joint publications

Mikko Hänninen

1 joint publications

Mélanie Vausort